Table 1 Baseline patient characteristics.
UPN | Sex | Age | Duration of AHD (months) | AHD type | MDS subtype (FAB) | MDS subtype (WHO) | IPSS-R | Transformation to AML | Cause of death | Cytogenetic abnormalities | Follow up time (years) | Sampling moments( n) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | F | 51 | 7 | Anaemia | RAEB | RAEB-1 | High | No | NA | del5q, t(X;16) | 11.2 | 19 |
2 | M | 62 | 7 | Anaemia | RARS | RARS | Very low | No | TBC | NN | 5.0 | 5 |
3 | M | 56 | 40 | Anaemia | RARS | RARS | Very low | No | Prostate cancer | NN | 7.7 | 6 |
4 | M | 66 | 43 | Granulocytopenia | RAEB | RAEB-1 | Low | No | NA | NN | 8.1 | 9 |
5 | M | 64 | 66 | Thrombocytopenia | RA | RCMD | Int | Yes | AML | +8 | 7.0 | 6 |
6 | M | 58 | 6 | Anaemia | RARS | RCMD | Low | No | MDS/pneumonia | +21 | 5.3 | 5 |
7 | M | 67 | 81 | Pancytopenia | RAEB | RAEB-1 | Int | Yes | AML | NN | 3.7 | 7 |
8 | F | 67 | 40 | Anaemia, Granulocytopenia | RAEB | RAEB-1 | Int | No | NA | del5q, t(1;10) | 11.3 | 13 |
9 | F | 73 | 69 | Anaemia | RA | RA | Low | No | Heart failure | del5q, del9q | 6.6 | 13 |
10 | F | 57 | 70 | Thrombocytosis | RA | RCMD | Int | No | NA | del5q, del13q | 9.3 | 31 |
11 | M | 67 | 0 | NA | RA | RCMD | Int | Yes | AML | NN | 2.4 | 6 |
